tirzepatide weight loss clinical trial At a glance factsheet: for management of type 2 diabetes Tirzepatide weight-loss study shows promising

Writing in The Lancet Psychiatry, the authors said GLP-1 receptor agonists semaglutide and liraglutide, sold under the brand name Saxenda, were associated with lower risk of worsening mental illness compared to non-use of this type of drug

Dose-related depression risk has not been systematically studied, but some patients report mood changes at any dose level

Patient counseling on slow titration and proper nutrition is paramount

The key for us is helping [these clients] maintain lean muscle mass, Gary tells SELF

Avoid skipping doses of semaglutide unless specifically instructed to skip the medication by your healthcare provider

10.1080/08830185.2017.1380200 Int Rev Immunol